Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Zesiewicz TA, Wilmot G, Kuo SH, Perlman S, Greenstein PE, Ying SH, Ashizawa T, Subramony SH, Schmahmann JD, Figueroa KP, Mizusawa H, Schöls L, Shaw JD, Dubinsky RM, Armstrong MJ, Gronseth GS, Sullivan KL.

Neurology. 2018 Feb 9. pii: 10.1212/WNL.0000000000005055. doi: 10.1212/WNL.0000000000005055. [Epub ahead of print]

PMID:
29440566
2.

Cerebellar TMS in treatment of a patient with cerebellar ataxia: evidence from clinical, biomechanics and neurophysiological assessments.

Farzan F, Wu Y, Manor B, Anastasio EM, Lough M, Novak V, Greenstein PE, Pascual-Leone A.

Cerebellum. 2013 Oct;12(5):707-12. doi: 10.1007/s12311-013-0485-8.

3.

A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.

Zesiewicz TA, Greenstein PE, Sullivan KL, Wecker L, Miller A, Jahan I, Chen R, Perlman SL.

Neurology. 2012 Feb 21;78(8):545-50. doi: 10.1212/WNL.0b013e318247cc7a. Epub 2012 Feb 8. Erratum in: Neurology. 2012 Jul 31;79(5):488.

PMID:
22323747
4.

Huntington's disease like-2 neuropathology.

Greenstein PE, Vonsattel JP, Margolis RL, Joseph JT.

Mov Disord. 2007 Jul 30;22(10):1416-23.

PMID:
17516481
5.

Drug induced liver injury secondary to interferon-beta (IFN-beta) in multiple sclerosis.

Byrnes V, Afdhal N, Challies T, Greenstein PE.

Ann Hepatol. 2006 Jan-Mar;5(1):56-9.

PMID:
16531969
6.

Nine families with the SCA3/Machado-Joseph disease type of inherited ataxia.

Greenstein PE, Moore D, Levy-Lohad E, Stephens K, Bird TD.

Neurology. 1996 Oct;47(4):1106-7. No abstract available.

PMID:
8857759

Supplemental Content

Loading ...
Support Center